These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3762266)

  • 1. Pharmacokinetics of droxicam in rat and dog.
    Esteve A; Martínez L; Roser R; Sagarra R
    Methods Find Exp Clin Pharmacol; 1986 Jul; 8(7):423-9. PubMed ID: 3762266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic profile of droxicam.
    Martínez L; Sánchez J
    Eur J Rheumatol Inflamm; 1991; 11(4):10-4. PubMed ID: 1365484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative study of the multiple dose pharmacokinetics and the tolerance of a new NSAID (droxicam) versus piroxicam in healthy volunteers.
    Martínez L; Sánchez J; Roser R; García-Barbal J; Bartlett A; Estruch J; Sagarra R; Puig S; Costa A
    Methods Find Exp Clin Pharmacol; 1988 Nov; 10(11):729-37. PubMed ID: 3221746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38alpha inhibitor: identification of an active metabolite in preclinical species and human liver microsomes.
    Kalgutkar AS; Hatch HL; Kosea F; Nguyen HT; Choo EF; McClure KF; Taylor TJ; Henne KR; Kuperman AV; Dombroski MA; Letavic MA
    Biopharm Drug Dispos; 2006 Nov; 27(8):371-86. PubMed ID: 16944451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological properties of droxicam, a new non-steroidal anti-inflammatory agent.
    Farré AJ; Colombo M; Fort M; Gutiérrez B; Rodríguez L; Roser R
    Methods Find Exp Clin Pharmacol; 1986 Jul; 8(7):407-22. PubMed ID: 3489870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-over study of the bioavailability of a new NSAID (droxicam) versus piroxicam in healthy volunteers following single and multiple dose administration.
    Bartlett A; Costa A; Martinez L; Roser R; Sagarra R; Sanchez J
    Eur J Drug Metab Pharmacokinet; 1992; 17(3):195-9. PubMed ID: 1490488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative bioavailability study to estimate the influence of an antacid on droxicam pharmacokinetics.
    Maya MT; Pais JP; Ruas Da Silva J; Morais JA
    Eur J Drug Metab Pharmacokinet; 1995; 20(4):275-9. PubMed ID: 8983932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pharmacokinetic study to evaluate the profile of droxicam in elderly healthy volunteers after a single oral dose of 20mg.
    Hosie J; Kelly J; Sánchez J; Bartlett A; Harrison FJ
    Eur J Rheumatol Inflamm; 1991; 11(4):45-9. PubMed ID: 1365490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of activated charcoal on the bioavailability of piroxicam in man.
    Laufen H; Leitold M
    Int J Clin Pharmacol Ther Toxicol; 1986 Jan; 24(1):48-52. PubMed ID: 3957490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of droxicam on in vivo prostaglandin synthesis and ex vivo platelet aggregation.
    Esteve J; Martínez L; Roser R; Sagarra R
    Methods Find Exp Clin Pharmacol; 1987 Apr; 9(4):209-13. PubMed ID: 3110512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism of piroxicam by laboratory animals.
    Hobbs DC; Twomey TM
    Drug Metab Dispos; 1981; 9(2):114-8. PubMed ID: 6113108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of intramuscular piroxicam.
    Fourtillan JB
    Eur J Rheumatol Inflamm; 1987; 8(1):38-41. PubMed ID: 3455202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and metabolism of the new thromboxane A2 receptor antagonist ramatroban in animals. 1st communication: absorption, concentrations in plasma, metabolism, and excretion after single administration to rats and dogs.
    Boberg M; Ahr HJ; Beckermann B; Bühner K; Siefert HM; Steinke W; Wünsche C; Hirayama M
    Arzneimittelforschung; 1997 Aug; 47(8):928-38. PubMed ID: 9296279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of gastric emptying on droxicam pharmacokinetics.
    Sánchez J; Martínez L; García-Barbal J; Roser R; Bartlett A; Sagarra R
    J Clin Pharmacol; 1989 Aug; 29(8):739-45. PubMed ID: 2778095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of mepindolol sulfate in the rat, dog, and rhesus monkey. Studies on species differences.
    Krause W; Kühne G
    Drug Metab Dispos; 1983; 11(2):91-6. PubMed ID: 6133729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disposition of ampiroxicam, a prodrug of piroxicam, in man.
    Falkner FC; Twomey TM; Borgers AP; Garg D; Weidler D; Gerber N; Browder IW
    Xenobiotica; 1990 Jun; 20(6):645-52. PubMed ID: 2219958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical pharmacokinetics of piroxicam.
    Verbeeck RK; Richardson CJ; Blocka KL
    J Rheumatol; 1986 Aug; 13(4):789-96. PubMed ID: 3490574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Piroxicam pharmacokinetics: recent clinical results relating kinetics and plasma levels to age, sex, and adverse effects.
    Hobbs DC
    Am J Med; 1986 Nov; 81(5B):22-8. PubMed ID: 3538867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of cimetidine on the pharmacokinetics of piroxicam in rat and man.
    Said SA; Foda AM
    Arzneimittelforschung; 1989 Jul; 39(7):790-2. PubMed ID: 2783182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of piroxicam in man.
    Hobbs DC
    Eur J Rheumatol Inflamm; 1983; 6(1):46-55. PubMed ID: 6861813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.